Related Experiment Video
Updated: Sep 10, 2025

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Association between Life's Crucial 9 and psoriatic arthritis in U.S. adults: a cross-sectional study
Jiefeng Jiang1,2, Lyuxin Guan3, Ziqin Gan4
1The First School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Insights
Higher cardiovascular health, measured by Life's Crucial 9 (LC9), is linked to a lower risk of psoriatic arthritis (PsA). Improving LC9 scores may help reduce PsA prevalence.
Area of Science:
- Cardiology
- Rheumatology
- Public Health
Background:
- Psoriatic arthritis (PsA) is associated with increased cardiovascular disease (CVD) risk.
- The relationship between Life's Crucial 9 (LC9) and PsA prevalence is not well-understood.
- LC9 offers a comprehensive assessment of cardiovascular health (CVH).
Purpose of the Study:
- To investigate the association between LC9 scores and PsA prevalence.
- To explore the implications of cardiovascular health on psoriatic arthritis risk.
Main Methods:
- Cross-sectional, population-based study using NHANES data (2005-2014) from 7,531 US adults.
- LC9 scores categorized into low, moderate, and high CVH levels.
- Logistic regression and restricted cubic splines analyzed the association between LC9 and PsA.
Main Results:
- Moderate to high CVH levels were associated with a significantly lower likelihood of PsA.
- A 10-point increase in LC9 score correlated with a 32% reduction in PsA odds.
- No significant association found between LC9 and psoriasis without arthritis (PsC).
Conclusions:
- LC9 scores and their components are inversely correlated with PsA risk.
- Adherence to LC9 lifestyle recommendations may lower PsA prevalence.
Background:
Psoriatic arthritis (PsA) has been closely associated with an elevated risk of cardiovascular disease (CVD). Nevertheless, the connection between Life's Crucial 9 (LC9), which serves as a holistic measure of cardiovascular health (CVH), and PsA remains insufficiently studied. This research aims to explore the potential relationship between LC9 and the prevalence of PsA.
Objective:
To investigate the role of LC9 in PsA and explore its implications.
Methods:
This study utilized a cross-sectional, population-based design, analyzing data from 7,531 U.S. participants aged 20 years or older, drawn from the 2005-2006 and 2009-2014 cycles of the National Health and Nutrition Examination Survey (NHANES). The LC9 score, which encompasses nine distinct components, was classified into three CVH categories: low, moderate, and high. To explore the association between LC9 scores and the prevalence of PsA, logistic regression models and restricted cubic splines were applied.
Results:
In the analyzed cohort of 7,531 individuals, participants with moderate or high CVH levels demonstrated a markedly reduced likelihood of developing PsA relative to those with low CVH. Additionally, a 10-point elevation in the LC9 score was associated with a 32% lower odds of having PsA. A notable interaction between LC9 and age was detected. Conversely, no meaningful link was found between LC9 and psoriasis without arthritis (PsC).
Conclusion:
The LC9 score and its subcomponents are significantly negatively correlated with the risk of PsA. This suggests that adherence to the lifestyle defined by LC9 is associated with a lower prevalence of PsA.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
The JAK-STAT Signaling Pathway
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Connective Tissue Cell Types
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...

